PATL1/PAT1b Antibody (Rabbit mAb) [N17C23]

製品コード:F8847

印刷

生物学的記述

Specificity PATL1/PAT1b Antibody (Rabbit mAb) [N17C23] detects endogenous levels of total PATL1/PAT1b protein.
Background PATL1, also known as Pat1b, is the human member of the conserved Pat1 family of mRNA decay factors. It moves mRNAs out of translation and into degradation through the main 5′-to-3′ decay pathway, in which the poly(A) tail is first shortened (deadenylation), the 5′ cap is then removed (decapping) and the transcript is finally digested by exonucleases. PATL1 is built from four regions: a conserved N-terminal sequence, an acidic and proline-rich segment, a Mid domain, and a C-terminal domain (Pat-C). Pat-C folds into an α-α superhelix with a conserved, basic surface that binds RNA and several decapping factors. PATL1 works mainly as a scaffold that physically links the deadenylation and decapping machineries. It binds tightly to the CCR4–CAF1–NOT deadenylase complex and to the DCP1–DCP2 decapping complex, and it also binds the RNA helicase Rck (DDX6) and the LSm1-7 ring, using at least three separate regions to hold these complexes together. Pat-C is essential for binding DCP2, the decapping enhancer EDC4 and LSm1-7. The proline-rich region strengthens DCP2 and EDC4 binding independently of LSm1-7, while LSm1-7 binding depends on the Mid domain and is weakened by the proline-rich segment. Several partners share the same basic surface of Pat-C, so some interactions are mutually exclusive, which lets PATL1 switch between decapping partners as an mRNA moves through successive steps of decay. Tethering PATL1 to a reporter mRNA promotes both deadenylation and decapping. PATL1 also controls the assembly of processing bodies (P-bodies), cytoplasmic foci rich in mRNA decay enzymes. Its aggregation-prone N-terminal region nucleates P-body formation, while its acidic region limits how large they grow.

使用情報

Application WB Dilution
WB
1:1000
Reactivity Human, Mouse, Rat, Monkey
Source Rabbit Monoclonal Antibody MW 87 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

References

  • https://pubmed.ncbi.nlm.nih.gov/20584987/
  • https://pubmed.ncbi.nlm.nih.gov/20543818/

Application Data